QED Investors
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA
- Canada
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Crypto
About
QED Investors is a premier venture Capital firm specializing in the fintech space, headquartered in Alexandria, Virginia. Founded by Nigel Morris and Frank Rotman, along with Caribou Honig in 2007, the firm leverages deep operational expertise and a commitment to fairness, transparency, and access to financial services. QED invests globally, with notable investments in Credit Karma, Pitzi, NuBank, Guiabolso, and Creditas. The team's 250 combined years of experience and a focus on unit economics drive their strategy. QED supports companies through their entire lifecycle from pre-seed to IPO, providing not just Capital but also extensive strategic and operational support.
QED Investors is a premier venture Capital firm specializing in the fintech space, headquartered in Alexandria, Virginia. Founded by Nigel Morris and Frank Rotman, along with Caribou Honig in 2007, the firm leverages deep operational expertise and a commitment to fairness, transparency, and access to financial services. QED invests globally, with notable investments in Credit Karma, Pitzi, NuBank, Guiabolso, and Creditas. The team's 250 combined years of experience and a focus on unit economics drive their strategy. QED supports companies through their entire lifecycle from pre-seed to IPO, providing not just Capital but also extensive strategic and operational support.
Investment Thesis
They invest in pragmatic disruptors who are the future of finance.
Portfolio
Tenpoint Therapeutics
Soda Health
Jasper Therapeutics
Tourmaline Bio
Satellos Bioscience
Abdera Therapeutics
Entact Bio
Auron Therapeutics
Boulder Care
Talaris Therapeutics
Elevation Oncology
HilleVax
Ventyx Biosciences
Korro Bio
Icosavax